| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protagonist Therapeutics, Inc. (PTGX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. PTGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 523.5K | $60.22M | - | |
| Other | 106.8K | $12.28M | - | |
| CFO | 60.8K | $6.99M | - | |
| Dir | 7.8K | $900.1K | - | |
| Dir | 7.8K | $900.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2018 | Liu David Y | Chief Scientific Officer | Sale+OE | 3,500 | $21.29 | $74,499.95 | -18.9% | |
| Mar 2, 2018 | Liu David Y | Chief Scientific Officer | Sale+OE | 875 | $20.00 | $17,500.00 | -6.2% | |
| Jan 16, 2018 | Liu David Y | Chief Scientific Officer | Sale+OE | 875 | $20.00 | $17,500.00 | -18.6% | |
| Dec 22, 2017 | Shames Richard S. | Chief Medical Officer | Sale+OE | 3,529 | $20.50 | $72,344.50 | -100% | |
| Dec 21, 2017 | Patel Dinesh V Ph D | President And CEO | Sale+OE | 8,210 | $19.56 | $160,569.54 | -4.1% | |
| Dec 20, 2017 | Patel Dinesh V Ph D | President And CEO | Sale+OE | 1,790 | $19.55 | $34,987.34 | -0.9% | |
| Dec 18, 2017 | Liu David Y | Chief Scientific Officer | Sale+OE | 875 | $20.00 | $17,500.00 | -18.6% | |
| Dec 18, 2017 | O'Neil Thomas P. | Chief Financial Officer | Sale+OE | 8,000 | $20.00 | $160,000.00 | -100% | |
| Nov 30, 2017 | Liu David Y | Chief Scientific Officer | Sale+OE | 875 | $20.00 | $17,500.00 | -18.6% | |
| Nov 13, 2017 | Liu David Y | Chief Scientific Officer | Sale+OE | 7,000 | $16.97 | $118,761.30 | -47.8% |